Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
Benjamin Kansy, Fernando Concha‐Benavente, Raghvendra M. Srivastava, et al.
Cancer Research (2017) Vol. 77, Iss. 22, pp. 6353-6364
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel, Diego Chowell, Timothy A. Chan
Nature reviews. Cancer (2019) Vol. 19, Iss. 3, pp. 133-150
Open Access | Times Cited: 1956
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood, Masoud Najafi, Keywan Mortezaee
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 8509-8521
Closed Access | Times Cited: 1321
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Daniela S. Thommen, Viktor H. Koelzer, Petra Herzig, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 994-1004
Open Access | Times Cited: 951
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
Shogo Kumagai, Yosuke Togashi, Takahiro Kamada, et al.
Nature Immunology (2020) Vol. 21, Iss. 11, pp. 1346-1358
Closed Access | Times Cited: 618
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
Anthony R. Cillo, Cornelius Kürten, Tracy Tabib, et al.
Immunity (2020) Vol. 52, Iss. 1, pp. 183-199.e9
Open Access | Times Cited: 541
Clinical implications of T cell exhaustion for cancer immunotherapy
Andrew Chow, Karlo Perica, Christopher A. Klebanoff, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 12, pp. 775-790
Open Access | Times Cited: 497
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
Jiaqiang Ma, Bohao Zheng, Shyamal Goswami, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 261
Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
Marc Oliva, Anna Spreafico, Miren Taberna, et al.
Annals of Oncology (2018) Vol. 30, Iss. 1, pp. 57-67
Open Access | Times Cited: 226
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy
Rami Yossef, Eric Tran, Drew C. Deniger, et al.
JCI Insight (2018) Vol. 3, Iss. 19
Open Access | Times Cited: 196
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
Areeg Elmusrati, Justin Wang, Cun‐Yu Wang
International Journal of Oral Science (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 194
Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing
Cornelius Kürten, Aditi Kulkarni, Anthony R. Cillo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 189
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment
Ayana T. Ruffin, Housaiyin Li, Lazar Vujanović, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 3, pp. 173-188
Open Access | Times Cited: 159
Single‐cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer
Jie Xia, Zhangjuan Xie, Gengming Niu, et al.
Immunology (2022) Vol. 168, Iss. 1, pp. 135-151
Open Access | Times Cited: 76
PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
Fernando Concha‐Benavente, Benjamin Kansy, Jessica Moskovitz, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 12, pp. 1548-1560
Open Access | Times Cited: 140
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine
Yee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 17, pp. 4242-4255
Open Access | Times Cited: 139
High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity
N. de Vries, Vincent van Unen, Marieke E. Ijsselsteijn, et al.
Gut (2019) Vol. 69, Iss. 4, pp. 691-703
Open Access | Times Cited: 109
PD-1 signaling affects cristae morphology and leads to mitochondrial dysfunction in human CD8+ T lymphocytes
Jesús Ogando, María Eugenia Sáez, Javier Varona Santos, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 106
Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy
Dongli Cai, Jiaming Li, Dingfeng Liu, et al.
Cellular and Molecular Immunology (2019) Vol. 17, Iss. 3, pp. 227-236
Open Access | Times Cited: 100
Radioimmunotherapy for the treatment of head and neck cancer
Sana D. Karam, David Raben
The Lancet Oncology (2019) Vol. 20, Iss. 8, pp. e404-e416
Closed Access | Times Cited: 93
Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer
Joe Yeong, Jeffrey Chun Tatt Lim, Bernett Lee, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 89
The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer
Xinwei Qiao, Jian Jiang, Xin Pang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 84
CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer
Alessia Echarti, Markus Hecht, Maike Büttner‐Herold, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1398-1398
Open Access | Times Cited: 77
T Lymphocyte-Captured DNA Network for Localized Immunotherapy
Chi Yao, Chenxu Zhu, Jianpu Tang, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 46, pp. 19330-19340
Closed Access | Times Cited: 75
Role of CD8+ T lymphocyte cells: Interplay with stromal cells in tumor microenvironment
Qin Xie, Jian Ding, Yi Chen
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 6, pp. 1365-1378
Open Access | Times Cited: 74
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
Brendan D. Curti, Yoshinobu Koguchi, Rom S. Leidner, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 4, pp. e002371-e002371
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top